0000950170-24-078173.txt : 20240627 0000950170-24-078173.hdr.sgml : 20240627 20240627083948 ACCESSION NUMBER: 0000950170-24-078173 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240626 FILED AS OF DATE: 20240627 DATE AS OF CHANGE: 20240627 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nabel Gary J. CENTRAL INDEX KEY: 0001867450 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40629 FILM NUMBER: 241075527 MAIL ADDRESS: STREET 1: C/O SIGA TECHNOLOGIES, INC. STREET 2: 31 EAST 62ND STREET CITY: NEW YORK STATE: NY ZIP: 10065 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Candel Therapeutics, Inc. CENTRAL INDEX KEY: 0001841387 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 522214851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 117 KENDRICK STREET STREET 2: SUITE 450 CITY: NEEDHAM STATE: MA ZIP: 02494 BUSINESS PHONE: 617-916-5445 MAIL ADDRESS: STREET 1: 117 KENDRICK STREET STREET 2: SUITE 450 CITY: NEEDHAM STATE: MA ZIP: 02494 FORMER COMPANY: FORMER CONFORMED NAME: Candel Therapeutics, Inic. DATE OF NAME CHANGE: 20210120 4 1 ownership.xml 4 X0508 4 2024-06-26 0001841387 Candel Therapeutics, Inc. CADL 0001867450 Nabel Gary J. C/O CANDEL THERAPEUTICS, INC. 117 KENDRICK ST., SUITE 450 NEEDHAM MA 02494 true false false false false Stock Option (Right to Buy) 5.71 2024-06-26 4 A false 14240 0 A 2034-06-26 Common Stock 14240 14240 D This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 26, 2025 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the "Board") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting. /s/ Charles Schoch, as Attorney-In-Fact for Gary J. Nabel 2024-06-27